{"id":2075,"date":"2022-10-18T11:11:54","date_gmt":"2022-10-18T11:11:54","guid":{"rendered":"https:\/\/funding.venturecenter.co.in\/news\/?p=2075"},"modified":"2022-10-18T11:11:54","modified_gmt":"2022-10-18T11:11:54","slug":"call-for-proposal-for-integrated-approach-to-address-support-covid-19-vaccine-induced-immunity-related-processes-and-facilities","status":"publish","type":"post","link":"https:\/\/funding.venturecenter.co.in\/news\/call-for-proposal-for-integrated-approach-to-address-support-covid-19-vaccine-induced-immunity-related-processes-and-facilities\/","title":{"rendered":"Call for proposal for Integrated approach to address\/support covid-19 vaccine induced immunity, related processes and facilities"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-lg-12 col-md-12 col-xs-12 col-sm-12\">\n<p style=\"font-weight: 400;\">Biotechnology Industry Research Assistance Council (BIRAC) has announced a call for proposals for Integrated approach to address\/support covid-19 vaccine induced immunity, related processes and facilities.<\/p>\n<p style=\"font-weight: 400;\">The Scope of the current call is development of treatments by accelerating pre-clinical &amp; clinical development and development of processes\/facilities for COVID associated conditions such as Pulmonary Fibrosis, Cystic fibrosis, Acute respiratory distress syndrome (ARDS), pro-thrombotic state and diffuse tissue injury, etc.<\/p>\n<p style=\"font-weight: 400;\"><strong>This may focus on-<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\">Development of treatment modalities<\/li>\n<li style=\"font-weight: 400;\">Invitro assays and In vivo animal models for lead molecule development.<\/li>\n<li style=\"font-weight: 400;\">Supporting capabilities for process development, cell line development and manufacturing of GMP batches for animal toxicology studies and clinical trials.<\/li>\n<\/ul>\n<p style=\"font-weight: 400;\">Please refer to<span>&nbsp;<\/span><strong>guidelines<\/strong><span>&nbsp;<\/span>and the advertisement for the application process, instructions, eligibility criteria and other relevant details for all categories.<\/p>\n<p style=\"font-weight: 400;\">Applications may be submitted online only through&nbsp;<span>&nbsp;<\/span><span><a href=\"https:\/\/www.birac.nic.in\/\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.birac.nic.in\/&amp;source=gmail&amp;ust=1666176652903000&amp;usg=AOvVaw3GFWJOZsM7yPRgmlyEaz9s\">BIRAC Website<\/a><\/span>. The guideline document may be downloaded from<span>&nbsp;<\/span><span><a href=\"https:\/\/www.birac.nic.in\/desc_new.php?id=972\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.birac.nic.in\/desc_new.php?id%3D972&amp;source=gmail&amp;ust=1666176652903000&amp;usg=AOvVaw3XpCCtSnqkwGqKMx-Lvypg\">https:\/\/www.birac.nic.in\/desc_new.php?id=972<\/a><\/span>.<span>&nbsp;<\/span>&nbsp;<strong>The last date for submission of proposals is 03 November, 2022, 5.00 PM<\/strong>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Biotechnology Industry Research Assistance Council (BIRAC) has announced a call for proposals for Integrated approach to address\/support covid-19 vaccine induced immunity, related processes and facilities. The Scope of the current call is development of treatments by accelerating pre-clinical &amp; clinical development and development of processes\/facilities for COVID associated conditions such as Pulmonary Fibrosis, Cystic fibrosis,&hellip; <a href=\"https:\/\/funding.venturecenter.co.in\/news\/call-for-proposal-for-integrated-approach-to-address-support-covid-19-vaccine-induced-immunity-related-processes-and-facilities\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Call for proposal for Integrated approach to address\/support covid-19 vaccine induced immunity, related processes and facilities<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2075","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts\/2075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/comments?post=2075"}],"version-history":[{"count":1,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts\/2075\/revisions"}],"predecessor-version":[{"id":2077,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/posts\/2075\/revisions\/2077"}],"wp:attachment":[{"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/media?parent=2075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/categories?post=2075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/funding.venturecenter.co.in\/news\/wp-json\/wp\/v2\/tags?post=2075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}